Don’t look now, but Cathie Wood of Ark Invest is fresh off an impressive comeback year, with her broader basket of disruptive ...

Genomics, Inc. (NASDAQ:TXG – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the ...

Cathie Wood-led Ark Invest made significant trades involving CRSP, TXG, RBLX, ACHR, NU, ADYEY, ACCD, and AVAV.

Cathie Wood's ARK ETFs published their daily trades for Friday, January 31st, 2025, with a notable emphasis on the biotech sector. Leading the charge in purchases was CRISPR Therapeutics AG ...

EST Cathie Wood’s ARK Investment buys 370K shares of 10x Genomics (TXG) todayInvest with Confidence: Follow TipRanks' Top Wall Street ...

Nisa Investment Advisors LLC acquired a new position in shares of 10x Genomics, Inc. (NASDAQ:TXG – Free Report) in the 4th quarter, HoldingsChannel reports. The firm acquired 16,500 shares of the ...

Cathie Wood's ARK ETFs have made their daily trades public for Wednesday, 29 January 2025, showcasing a series of strategic moves in the tech and biotech sectors. The most significant purchase was in ...

CEO Serge Saxonov, PhD, says provider of single cell, spatial, and in situ instruments expects to see benefits from sales ...

X Genomics Inc (TXG) stock saw a decline, ending the day at $14.84 which represents a decrease of $-0.01 or -0.07% from the prior close of $14.85. The stock opened at $14.99 and touched a low of ...

The next-generation sequencing market valued at US$ 13.92 billion in 2023, is forecasted to grow at a robust CAGR of 11.0%, reaching US$ 13.28 ...